geranylacetone has been researched along with Alzheimer Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marumoto, S; Miyazawa, M; Okuno, Y | 1 |
1 other study(ies) available for geranylacetone and Alzheimer Disease
Article | Year |
---|---|
Inhibition of β-Secretase Activity by Monoterpenes, Sesquiterpenes, and C
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Camphanes; Camphor; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; In Vitro Techniques; Molecular Targeted Therapy; Monoterpenes; Norbornanes; Norisoprenoids; Phytotherapy; Recombinant Proteins; Sesquiterpenes; Terpenes | 2017 |